Back to search
FDAFDA · Food and drugs·Recall number D-1381-2020

Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only, Manufactured by: Biogen Inc., Cambridge, MA 02142, NDC 64406-006-02

Published July 15, 2020 · Recall initiated: June 23, 2020

Summary

FDA records drug Class III recall D-1381-2020, published July 15, 2020 and initiated June 23, 2020. Recalling firm: Biogen MA Inc.; Status: Terminated; Reported quantity: 3,922 bottles; Lot: Lot # SH0274, Exp 2/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

What to do

Voluntary: Firm initiated · Letter

Get an email if TECFIDERA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TECFIDERA
Manufacturer
Biogen MA Inc.
Distributor
Product was distributed to wholesalers/distributors in KY, OH & MS.
UPC
0364406005015
Lot
Lot # SH0274, Exp 2/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only, Manufactured by: Biogen Inc., Cambridge, MA 02142, NDC 64406-006-02 recalled?

Yes. FDA published recall D-1381-2020 on July 15, 2020. Reported hazard: cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TECFIDERA. UPC: 0364406005015.